JIN,HAOLUN,金浩仑,金浩崙,LAZERWITH,SCOTT E.,拉泽威斯史考特,拉澤威斯史考特,MARTIN,TERESA ALEJANDRA TREJO,马丁泰瑞莎,馬丁泰瑞莎,BACON, ELIZABETH M.,贝肯 伊丽莎白,貝肯 伊麗莎白,COTTELL,JEROMY J.,科特尔杰若米,科特爾傑若米,CAI,ZHENHONG R.,蔡珍红,蔡珍紅,PYUN,HYUNG-J
申请号：
TW107127529
公开号：
TW201918485A
申请日:
2013.12.19
申请国别(地区):
TW
年份:
2019
代理人:
摘要：
Compounds for use in the treatment of human immunodeficiency virus (HIV) infection are disclosed. The compounds have the following Formula (I):including stereoisomers and pharmaceutically acceptable salts thereof, wherein R1, X, W, Y1, Y2, Z1, and Z4 are as defined herein. Methods associated with preparation and use of such compounds, as well as pharmaceutical compositions comprising such compounds, are also disclosed.本發明揭示用於治療人類免疫不全病毒(HIV)感染之化合物。此類化合物具有下式(I)：包括其立體異構物和醫藥上可接受的鹽，其中R1、X、W、Y1、Y2、Z1、和Z4係如本文中所定義。本發明亦揭示有關此類化合物之製備和使用的方法，以及包含此類化合物之醫藥組成物。
